Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aducanumab
aducanumab
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
GoInPharma
Thu, 08/17/17 - 11:47 pm
Biogen
Alzheimer's disease
aducanumab
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet
Motley Fool
Sun, 07/23/17 - 11:47 am
Biogen
aducanumab
JNJ
apalutamide
Eli Lilly
abemaciclib
AbbVie
Rova-T
Celgene
ozanimod
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Alzheimer's disease
anti-amyloid
solanezumab
Eli Lilly
Biogen
aducanumab
RVT-101
Over And Out For Solanezumab, While Biogen Takes The Spotlight
Seeking Alpha
Tue, 12/13/16 - 10:22 am
solanezumab
Biogen
Eli Lilly
aducanumab
Alzheimer's disease
Why the latest Alzheimer’s data is (mostly) great news for Biogen
Bizjournals.com
Sun, 12/11/16 - 11:52 am
Alzheimer's disease
Biogen
aducanumab
Can Biogen solve the Alzheimer’s drug riddle? We could find out within days
Bizjournals.com
Thu, 12/8/16 - 09:55 am
Biogen
Alzheimer's disease
aducanumab
clinical trials
Could This Alzheimer’s Disease Drug Really Be Worth $20 Billion?
Motley Fool
Mon, 09/19/16 - 03:41 pm
Biogen
Alzheimer's disease
aducanumab
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Will MS Franchise & New Drugs Come To Biogen Rescue?
Bidness, ETC
Wed, 09/7/16 - 08:10 pm
Biogen
MS
multiple sclerosis
Nusinersen
SMA
aducanumab
Alzheimer's disease
Biogen Inc to Surge on FDA Win of Alzheimer’s Drug
Bidness, ETC
Fri, 09/2/16 - 09:49 am
Biogen
Alzheimer's disease
FDA
fast track
aducanumab
Biogen’s aducanumab data impress the media, but not the market
Fierce Biotech
Thu, 09/1/16 - 09:37 am
Biogen
aducanumab
Alzheimer's disease
Biogen touts a fresh set of early, upbeat results for Alzheimer’s drug
Endpoints
Wed, 08/31/16 - 08:53 pm
Biogen
Alzheimer's disease
aducanumab
The Best-Selling Drugs in the World By 2020
Motley Fool
Sat, 09/26/15 - 09:59 am
Harvoni
Gilead Sciences
Revlimid
Celgene
aducanumab
Biogen
Here's Why Biogen Lost $20 Billion in Market Value in July
Motley Fool
Thu, 08/6/15 - 08:34 am
Biogen
aducanumab
Alzheimer's disease
Ambiguous Trial Data For Biogen Bites Stock
Yahoo/Investors.com
Wed, 07/22/15 - 09:47 pm
Biogen
aducanumab
Alzheimer's disease
Big Week for Biogen
Motley Fool
Tue, 07/21/15 - 07:12 pm
Biogen
earnings
Alzheimer's disease
aducanumab
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
WSJ Pharmalot
Mon, 07/20/15 - 11:01 pm
Eli Lilly
Biogen
clinical trials
Alzheimer's disease
aducanumab
solanezumab
Has Biogen found the 'Goldilocks' dose for Alzheimer's drug?
CNBC
Sat, 07/18/15 - 10:54 am
Biogen
Alzheimer's disease
aducanumab
Why next week's Alzheimer’s drug trial results from Biogen will be closely watched
Bizjournals.com
Tue, 07/14/15 - 10:45 pm
Biogen
Alzheimer's disease
aducanumab
3 Long Shots Biotech Companies Are Working On
Motley Fool
Sat, 07/11/15 - 10:27 am
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »